Month: July 2021

The following items on the agenda were approved at Icelandair Group’s shareholders’  meeting on 23 July 2021: Proposals: 1.            A proposal to increase the Company’s share capital in relation to a subscription agreement made with Blue Issuer Designated Activity Company and affiliates The Board of Directors of Icelandair Group hf. submitted the following proposal, to increase the share capital of Icelandair Group by issuing new shares. “The shareholders‘ meeting of Icelandair Group hf. held on 23 July 2021, resolves to increase the Company‘s share capital of ISK 5,659,094,470, from ISK 28,437,660,653 to ISK 34,096,755,123, nominal value, by issuing new shares. According to an agreement to subscribe for shares dated 23 June 2021 Blue Issuer Designated Activity Company has subject to the provisions of the agreement, which include...

Bollène, July 23, 2021– 06 :00 pm (CET)Press Release 1st HALF 2021 REVENUE1st half 2021 revenue was €16,59 m: + 30.7% compared to S2 2020.Egide SA grew at +2.3% compared to S2 2020, and 16.3% YoYEgide USA grew at + 146.7% (in $) compared to S2 2020, although -2.9% YoY as the plating operation became gradually operational during the semester. Santier also bounced up at +14.1% (in $) compared to S2 2020, yet – 13 YoY%OUTLOOKGroup revenue target is maintained for 2021. Egide USA plating operation will be 100% operational early in Q3 2021Egide group’s unaudited consolidated revenues for the first half of 2021 strongly grew to €16.59 million (+ 30.7%) compared to S2 2020 fueled by strong rebound at Santier and at Egide USA who has progressively resumed its plating activity. At constant exchange rates, compared...

Asset Quality, Commercial Banking Momentum, Active Mortgage Lending LYNCHBURG, Va., July 23, 2021 (GLOBE NEWSWIRE) — Bank of the James Financial Group, Inc. (the “Company”) (NASDAQ:BOTJ), the parent company of Bank of the James, a full-service commercial and retail bank serving Region 2000 (the greater Lynchburg MSA), and the Blacksburg, Charlottesville, Harrisonburg, Lexington, and Roanoke, Virginia markets, today announced unaudited results for the three and six month periods ended June 30, 2021. Net income for the three months ended June 30, 2021 was $2.01 million or $0.42 per diluted share compared with $821 thousand or $0.17 per diluted share for the three months ended June 30, 2020. For the six months ended June 30, 2021, net income was $3.85 million or $0.81 per diluted share compared with $1.82 million or $0.38 million...

Beter Bed Holding N.V. (“BBH” ISIN NL0000339703), the Netherlands’ leading sleep specialist in retail, wholesale and B2B, announces the issue of 946,167 new ordinary shares of the Company against an issue price of € 6.82. The issue of shares is meant to remediate the impact on the Company’s solvency from the repayment of the perpetual loan, as announced in the interim results press release dated 21 July 2021. The net proceeds of the Offering will be used to strengthen our financial position and to provide the Company with the financial flexibility to accelerate the execution of its growth strategy 2025 as presented during the AGM of 12 May 2021. The increased attention for health and well-being, due to COVID-19, is expected to lead to increased demand for quality sleep as one of the three pillars of health. The investment program driven...

PORTLAND, Maine, July 23, 2021 (GLOBE NEWSWIRE) — Northeast Bank (the “Bank”) (NASDAQ: NBN), a Maine-based full-service bank, announced today it will release its fiscal 2021 fourth quarter earnings results on Wednesday, July 28, 2021. Following the release, the Bank will host a conference call with a simultaneous webcast at 10:00 a.m. ET on Thursday, July 29, 2021. The conference call will be hosted by Rick Wayne, President and Chief Executive Officer, JP Lapointe, Chief Financial Officer, and Pat Dignan, Executive Vice President and Chief Credit Officer. Investors can access the call by dialing 800.773.2954 and providing the following conference ID#: 50197423. The call will be available via live webcast, which can be viewed by accessing the Bank’s website at www.northeastbank.com and clicking on the Investor Relations section....

China Oncology Focus, a subsidiary of Lee’s Pharm, has enrolled the first patient in the Socazolimab double-blinded Phase 3 study in combination with chemotherapy as a first-line treatment of extensive-stage small-cell lung cancer. Socazolimab is an anti-PD-L1 antibody licensed from Sorrento for the Greater China Territory by Lee’s Pharm.SAN DIEGO, July 23, 2021 (GLOBE NEWSWIRE) — Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”) and Lee’s Pharmaceutical Holdings Limited (HKEX: 950, “Lee’s Pharm”) announced today that, on July 15, 2021, China Oncology Focus Limited (“COF”), a subsidiary of Lee’s Pharm, has enrolled the first patient in China in the Phase 3, multicenter, randomized, double blinded, placebo controlled clinical trial of Socazolimab (anti-PD-L1 monoclonal antibody, formerly known as ZKAB001) combined with chemotherapy...

GREENWICH, Conn., July 23, 2021 (GLOBE NEWSWIRE) — Oxford Lane Capital Corp. (Nasdaq: OXLC) (NasdaqGS: OXLCM) (NasdaqGS: OXLCP) (NasdaqGS: OXLCL) announced today that it will hold a conference call to discuss its first fiscal quarter earnings on Friday, July 30, 2021 at 9:00 AM ET. The toll free dial-in number is 1-844-792-3730. There will be a recorded replay of the call available for 30 days after the call. If you are interested in hearing the recording, please dial 1-877-344-7529. The replay pass-code number is 10159101.     About Oxford Lane Capital Corp. Oxford Lane Capital Corp. is a publicly-traded registered closed-end management investment company principally investing in debt and equity tranches of collateralized loan obligation (“CLO”) vehicles. CLO investments may also include warehouse facilities, which are financing...

FDA Type C meeting minutes provide clarity on the Phase 2/3 study design for RAD011 505(b)(2) regulatory strategy: acceptable approach upon completion of PK & food effect studies Based on results, a single well controlled study could serve as the basis for marketing approval RAD011 had previously been granted Orphan Drug and Fast Track Designation by the FDA Study initiation targeted by end of year or early first quarter of 2022BOSTON, July 23, 2021 (GLOBE NEWSWIRE) — A correction has been issued for a release disseminated under the same headline on July 22nd at 9:00 am EST by Radius Health, Inc. (RDUS), please note that the corrected release contains the revised statement with the typographical correction as follows: “RAD011 is not scheduled as it does not have traceable amounts of THC,” which has been corrected from “does...

The private placement forms part of the previously announced financing, which included a public offering of US$59.4 million which was completed in June 2021 Investissement Québec, acting as mandatary for the government of Québec, shows strong ongoing support, subscribing for the full amount of the private placementMONTREAL, July 23, 2021 (GLOBE NEWSWIRE) — Nouveau Monde Graphite Inc. (“Nouveau Monde” or the “Company”) (NYSE: NMG, TSXV: NOU; Frankfurt: NM9A) is pleased to announce that it has closed the non-brokered private placement (the “Private Placement”) of common shares of the Company previously announced on June 15, 18 and 23, 2021. The Private Placement was launched concurrently with the public offering of US$59.4 million of the Company, which closed on June 23, 2021. Pursuant to the Private Placement, the Company issued...